Open AccessP973: REAL‐WORLD STUDY ON ADOPTION OF STANDARD OF CARE (SOC) FOR FRONTLINE TRANSPLANT‐ELIGIBLE MULTIPLE MYELOMA (FLTEMM) PATIENTS BETWEEN 2017 AND 2020/2021 ACROSS FRANCE, GERMANY, SPAIN, AND ITALY
Author(s) -
Weisel K.,
Wadlund A.,
Gungor G.,
Dergarabetian E.,
Pacheco C.,
Masurkar N.,
RodriguezOtero P.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846760.84498.70
Subject(s) - medicine , regimen , bortezomib , lenalidomide , population , multiple myeloma , transplantation , thalidomide , environmental health